Global health R&D at work in Tennessee
Duke University scientists are working to advance a pan-coronavirus vaccine that could protect against multiple coronaviruses. Within months of the emergence of the COVID-19 pandemic, Duke researchers developed a candidate vaccine and validated its proof of concept in preclinical studies. Now, the Duke Human Vaccine Institute, with support from the US National Institutes of Health, is manufacturing doses for upcoming human clinical trials. Given coronaviruses are a family of viruses with a high likelihood of spurring future epidemics and pandemics, such a vaccine would be a powerful new tool for improving health preparedness.